Avid Bioservices, Inc. today presented data highlighting the comparability of production run performance between the company's single-use bioreactors (Thermo Scientific HyClone S.U.B.) and its traditional stainless steel bioreactors at the Thermo Scientific BioProduction Optimization Workshop in San Francisco, California. The presentation included cell culture performance data comparing multiple stainless steel and S.U.B. production runs at the 1000-liter scale in the company's cGMP manufacturing facility in Tustin, CA.
"Our HyClone S.U.B. system provides important consistency, scalability and efficiencies in our cGMP biomanufacturing services," said Richard Richieri, Avid's senior vice president, technical operations. "Data from both the 1000 and 100 liter S.U.B. show our process is consistent and scalable, allowing us considerable flexibility to manufacture products using either the S.U.B. or traditional stainless steel bioreactor systems to meet our clients' clinical trial materials requirements. The manufacturing efficiencies from using our S.U.B., including reduced changeover time between manufacturing runs and shortened project timelines, are critical as we support our clients' clinical and commercial production needs."
Thermo Fisher Scientific expands deployment model options for SampleManager LIMS software